RESUMEN
Acute stress is a physiological response of an organism to adverse conditions, contributing to survival; however, persistence through time may lead to disease. Indeed, exacerbation of inflammatory conditions such as psoriasis has been reported to follow stressors in susceptible patients. Because chronic stress cannot ethically be elicited in patients under controlled laboratory conditions, we studied genetically modified mice that naturally develop psoriasiform dermatitis, and subjected them to an ethological chronic social contact stress paradigm. Although we found elevated pro-inflammatory neuropeptide production of substance P (SP), calcitonin-gene-related peptide (CGRP) and nerve-growth factor (NGF) mRNA in the dorsal root ganglia (DRG) as well as pro-inflammatory cytokines in response to the social stressor, stress paradoxically prevented the development of the skin lesions. This effect of stress could be reversed by the treatment with glucocorticoid (GC) receptor blockers, suggesting that it was mediated through the upregulation of corticosterone secretion. Extrapolating to humans, the worsening of disease in susceptible patients with psoriasis could be attributed to a defect in the Hypothalamic-Pituitary-Adrenal (HPA) axis with an impaired production of GC during situations of adversity, thus rendering them unable to counteract the pro-inflammatory effects of chronic stressors.
Asunto(s)
Psoriasis/fisiopatología , Estrés Psicológico/metabolismo , Corticoesteroides/metabolismo , Animales , Péptido Relacionado con Gen de Calcitonina , Corticosterona/farmacología , Dermatitis , Modelos Animales de Enfermedad , Ganglios Espinales/metabolismo , Sistema Hipotálamo-Hipofisario/metabolismo , Masculino , Ratones , Ratones Transgénicos , Factor de Crecimiento Nervioso , Neuropéptidos , Sistema Hipófiso-Suprarrenal/metabolismo , Psoriasis/metabolismo , ARN Mensajero , Receptores de Glucocorticoides/metabolismo , Estrés Psicológico/genética , Sustancia P , Activación Transcripcional , Regulación hacia ArribaRESUMEN
Aldo-keto reductase 1C3 (AKR1C3) is an enzyme involved in metabolizing prostaglandins (PGs) and sex hormones. It metabolizes PGD2 to 9α11ß-PGF2 , diverting the spontaneous conversion of PGD2 to the PPARγ agonist, 15-Deoxy-Delta-12, 14-prostaglandin J2 (15d-PGJ2 ). AKR1C3 is overexpressed in various malignancies, suggesting a tumor promoting function. This work investigates AKR1C3 expression in human non-melanoma skin cancers, revealing overexpression in squamous cell carcinoma (SCC). Effects of AKR1C3 overexpression were then evaluated using three SCC cell lines. AKR1C3 was detected in all SCC cell lines and its expression was upregulated in response to its substrate, PGD2 . Although attenuating AKR1C3 expression in SCC cells by siRNA did not affect growth, treatment with PGD2 and its dehydration metabolite, 15d-PGJ2 , decreased SCC proliferation in a PPARγ-dependent manner. In addition, treatment with the PPARγ agonist pioglitazone profoundly inhibited SCC proliferation. Finally, we generated an SCC cell line that stably overexpressed AKR1C3 (SCC-AKR1C3). SCC-AKR1C3 metabolized PGD2 to 9α11ß-PGF2 12-fold faster than the parent cell line and was protected from the antiproliferative effect mediated by PGD2 . This work suggests that PGD2 and its metabolite 15d-PGJ2 attenuate SCC proliferation in a PPARγ-dependent manner, therefore activation of PPARγ by agonists such as pioglitazone may benefit those at high risk of SCC.
Asunto(s)
3-Hidroxiesteroide Deshidrogenasas/metabolismo , Carcinoma de Células Escamosas/metabolismo , Regulación Neoplásica de la Expresión Génica/fisiología , Hidroxiprostaglandina Deshidrogenasas/metabolismo , Prostaglandinas/metabolismo , Neoplasias Cutáneas/metabolismo , Regulación hacia Arriba/fisiología , Miembro C3 de la Familia 1 de las Aldo-Ceto Reductasas , Carcinoma de Células Escamosas/genética , Carcinoma de Células Escamosas/patología , Línea Celular Tumoral , Proliferación Celular , Células Cultivadas , Humanos , PPAR gamma/metabolismo , Prostaglandina D2/análogos & derivados , Prostaglandina D2/metabolismo , Prostaglandina D2/farmacología , ARN Interferente Pequeño/farmacología , Piel/efectos de los fármacos , Piel/metabolismo , Piel/patología , Neoplasias Cutáneas/genética , Neoplasias Cutáneas/patologíaRESUMEN
This study explores the effects of stress and housing conditions on the healing of cutaneous wounds and its relationship with circulating levels of corticosterone. Specifically, we set out to examine the effect of combined physical (restraint stress and ultrasound) and psychological (predator scent) stressors on the cutaneous wound healing of female mice that had been housed either in groups (with social support; n= 16) or individually (without social support; n= 16). In contrast with other studies, the model of multiple ethological mild stressors utilized in this study significantly increased the levels of corticosterone, but failed to dramatically alter the healing of skin wounds. However, the results of this study provide evidence of the importance of housing conditions, suggesting that positive social interactions in females accelerate the rate of wound healing, and reduce levels of anxiety and circulating corticosterone. The level of anxiety, as well as the basal levels of corticosterone, proved to be valid predictors of the healing rates during different stages of cutaneous wound healing (AU)
Este trabajo explora los efectos del estrés y de las condiciones de alojamiento, en el proceso de cicatrización de heridas cutáneas, y su relación con los niveles de corticosterona circulante. Concretamente, proponemos examinar el efecto combinado de estresores físicos (estrés por inmovilización y ultrasonidos) y psicológicos (olor de un depredador), en la cicatrización de heridas cutáneas en ratones hembras alojados en grupo (con apoyo social; n= 16) o individualmente (sin apoyo social; n= 16). Frente a otros estudios, el modelo etológico de estresores medios múltiples utilizado en este trabajo incrementó los niveles de corticosterona, pero no alteró de manera significativa el proceso de cicatrización de las heridas en la piel. Sin embargo, los resultados de este estudio muestran la importancia de las condiciones de alojamiento, sugiriendo que las interacciones sociales positivas en hembras aceleran el proceso de cicatrización de las heridas y reducen los niveles de ansiedad y de corticosterona circulante. Tanto el nivel de ansiedad como los niveles de corticosterona basal mostraron ser predictores válidos del nivel de cicatrización en diferentes momentos del proceso de curación de heridas cutáneas (AU)
Asunto(s)
Humanos , Masculino , Femenino , Estrés Psicológico/complicaciones , Estrés Psicológico/diagnóstico , Estrés Psicológico/psicología , Cicatrización de Heridas/fisiología , Apoyo Social , Ansiedad/psicología , Trastornos de Ansiedad/psicología , Escala de Ansiedad ante Pruebas/estadística & datos numéricos , Corticosterona/uso terapéutico , Ensayo de Inmunoadsorción Enzimática/métodos , Análisis de VarianzaRESUMEN
This study explores the effects of stress and housing conditions on the healing of cutaneous wounds and its relationship with circulating levels of corticosterone. Specifically, we set out to examine the effect of combined physical (restraint stress and ultrasound) and psychological (predator scent) stressors on the cutaneous wound healing of female mice that had been housed either in groups (with social support; n= 16) or individually (without social support; n= 16). In contrast with other studies, the model of multiple ethological mild stressors utilized in this study significantly increased the levels of corticosterone, but failed to dramatically alter the healing of skin wounds. However, the results of this study provide evidence of the importance of housing conditions, suggesting that positive social interactions in females accelerate the rate of wound healing, and reduce levels of anxiety and circulating corticosterone. The level of anxiety, as well as the basal levels of corticosterone, proved to be valid predictors of the healing rates during different stages of cutaneous wound healing.
Asunto(s)
Vivienda , Piel , Estrés Psicológico/complicaciones , Cicatrización de Heridas , Animales , Corticosterona/sangre , Femenino , Ratones , Estrés Psicológico/sangre , Factores de TiempoRESUMEN
Aldo-keto reductase 1C3 (AKR1C3) has been shown to mediate the metabolism of sex hormones and prostaglandin D(2) (PGD(2)), a lipid mediator that promotes skin inflammation in atopic dermatitis (AD). As both have a role in skin function and pathology, we first sought to investigate the expression pattern of AKR1C3 in normal human epidermis. Immunofluorescence revealed a strong expression of AKR1C3 in the differentiated suprabasal layers compared with the basal layer. Western blot analysis and quantitative PCR confirmed that AKR1C3 expression was also upregulated in differentiation-induced primary human keratinocytes (PHKs). To investigate the functional role of AKR1C3 during PHK differentiation, its expression and activity (measured as PGD(2) reduction to 9α,11ß-PGF(2) by ELISA) were impaired by small interfering RNA or 2'-hydroxyflavanone, respectively. Cytokeratin 10 (K10) and loricrin expression were then examined by western blot analysis, thus revealing altered expression of these differentiation markers. Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions. AKR1C3 was found to be upregulated in AD but not in psoriasis lesions compared with non-lesional skin. Our work demonstrates a function for AKR1C3 in differentiation-associated gene regulation and also suggests a role in supporting inflammation in AD.
Asunto(s)
3-Hidroxiesteroide Deshidrogenasas/metabolismo , Diferenciación Celular/fisiología , Dermatitis Atópica/metabolismo , Epidermis/metabolismo , Hidroxiprostaglandina Deshidrogenasas/metabolismo , Queratinocitos/citología , Queratinocitos/metabolismo , Regulación hacia Arriba/fisiología , 3-Hidroxiesteroide Deshidrogenasas/genética , Miembro C3 de la Familia 1 de las Aldo-Ceto Reductasas , Biomarcadores/metabolismo , Calcio/metabolismo , Diferenciación Celular/efectos de los fármacos , Células Cultivadas , Dermatitis Atópica/patología , Dermatitis Atópica/fisiopatología , Células Epidérmicas , Epidermis/efectos de los fármacos , Flavanonas/farmacología , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Hidroxiprostaglandina Deshidrogenasas/genética , Queratina-10/metabolismo , Queratinocitos/efectos de los fármacos , Proteínas de la Membrana/metabolismo , Prostaglandina D2/metabolismo , ARN Interferente Pequeño/farmacología , Regulación hacia Arriba/efectos de los fármacosRESUMEN
BACKGROUND: Recent work suggests that injuries can heal faster if treated by lasers emitting 670-nm red light. LED lights emitting 670-nm light are now available. This suggests that inexpensive and easy-to-use 670-nm LED lights might help accelerate cutaneous wound healing. OBJECTIVE: The objective was to evaluate the effect of 670-nm LED light on wound healing in SKH-1 hairless mice. METHODS: To study 670-nm light effects on incisional injury, animals were left unexposed or exposed to equal doses of high-, medium-, or low-flux light. Burn injuries were treated with high-flux light or left unexposed. Healing was assessed by measurement of the burn area and the gap remaining to closure of incisional injury. RESULTS: Mice exposed to 670-nm red light showed significantly faster healing than control mice. High, medium, and low fluxes of light were all effective after incisional injury. In burn injury, there was improvement in wound healing initially, but the time to repair was unchanged. CONCLUSIONS: A 670-nm LED red light source accelerates healing in skin of SKH-1 hairless mice after incisional injuries, but is not as effective for burn injuries. These data that suggest red light exposure may be helpful in postoperative wound repair.
Asunto(s)
Terapia por Luz de Baja Intensidad , Cicatrización de Heridas/efectos de la radiación , Animales , Quemaduras/radioterapia , Modelos Animales de Enfermedad , Luz , Ratones , Ratones Pelados , Piel/lesiones , Piel/efectos de la radiación , Heridas Penetrantes/radioterapiaRESUMEN
The incidence of skin cancer is on the rise, with over 1 million new cases yearly. Although it is known that squamous cell cancers (SCC) are caused by UV light, the mechanism(s) involved remains poorly understood. In vitro studies with epithelial cells or reports examining malignant skin lesions suggest that loss of E-cadherin-mediated cell-cell contacts may contribute to SCCs. Other studies show a pivotal role for cyclooxygenase-dependent prostaglandin E2 (PGE2) synthesis in this process. Using chronically UV-irradiated SKH-1 mice, we show a sequential loss of E-cadherin-mediated cell-cell contacts as lesions progress from dysplasia to SCCs. This E-cadherin down-regulation was also evident after acute UV exposure in vivo. In both chronic and acute UV injury, E-cadherin levels declined at a time when epidermal PGE2 synthesis was enhanced. Inhibition of PGE2 synthesis by indomethacin in vitro, targeted deletion of EP2 in primary mouse keratinocyte (PMK) cultures or deletion of the EP2 receptor in vivo abrogated this UV-induced E-cadherin down-regulation. In contrast, addition of PGE2 or the EP2 receptor agonist butaprost to PMK produced a dose- and time-dependent decrease in E-cadherin. We also show that UV irradiation, via the PGE2-EP2 signaling pathway, may initiate tumorigenesis in keratinocytes by down-regulating E-cadherin-mediated cell-cell contacts through its mobilization away from the cell membrane, internalization into the cytoplasm, and shuttling through the lysosome and proteasome degradation pathways. Further understanding of how UV-PGE2-EP2 down-regulates E-cadherin may lead to novel chemopreventative strategies for the treatment of skin and other epithelial cancers.
Asunto(s)
Cadherinas/metabolismo , Carcinoma de Células Escamosas/metabolismo , Dinoprostona/metabolismo , Procesamiento Proteico-Postraduccional , Receptores de Prostaglandina E/metabolismo , Neoplasias Cutáneas/metabolismo , Animales , Cadherinas/biosíntesis , Cadherinas/deficiencia , Cadherinas/genética , Carcinoma de Células Escamosas/etiología , Carcinoma de Células Escamosas/genética , Carcinoma de Células Escamosas/patología , Procesos de Crecimiento Celular/fisiología , Dinoprostona/biosíntesis , Progresión de la Enfermedad , Regulación hacia Abajo , Regulación Neoplásica de la Expresión Génica , Lisosomas/metabolismo , Ratones , Ratones Pelados , Ratones Noqueados , Complejo de la Endopetidasa Proteasomal/metabolismo , Subtipo EP2 de Receptores de Prostaglandina E , Neoplasias Cutáneas/etiología , Neoplasias Cutáneas/genética , Neoplasias Cutáneas/patología , Rayos UltravioletaRESUMEN
Ultraviolet (UV) light is a complete carcinogen inducing and promoting squamous-cell carcinoma (SCC) of the skin. Recent work has shown that SCC initiation and promotion are enhanced by prostaglandin E2 (PGE2). PGE2 interacts with specific EP receptors to regulate cellular functions. Previous work from our group has shown that the prostaglandin E2 EP2 receptor is a powerful regulator of keratinocyte growth. SKH-1 hairless mice lacking the EP2 receptor were therefore studied to understand how this growth signaling pathway contributes to photocarcinogenesis. Our data indicate that UV-irradiated mice lacking EP2 receptors exhibit decreased proliferation and a poor capacity for epidermal hypertrophy in response to UV injury. In a chronic irradiation model, these animals were protected from tumor formation, developing 50% fewer tumors than wild-type controls. Despite this capacity to protect against tumorigenesis, animals lacking EP2 receptors grew tumors that were larger in size, with a more aggressive phenotype. Further study suggested that this susceptibility may be associated with synthesis of active metalloproteinase enzymes in greater quantities than keratinocytes expressing the EP2 receptor, thereby enhancing the invasive potential of EP2-/- cells.
Asunto(s)
Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/prevención & control , Receptores de Prostaglandina E/deficiencia , Receptores de Prostaglandina E/metabolismo , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/prevención & control , Rayos Ultravioleta , Animales , Carcinoma de Células Escamosas/etiología , Metaloproteinasas de la Matriz/metabolismo , Ratones , Ratones Noqueados , Ratones Desnudos , Invasividad Neoplásica , Neoplasias Inducidas por Radiación/patología , Neoplasias Inducidas por Radiación/prevención & control , Fenotipo , Subtipo EP2 de Receptores de Prostaglandina E , Neoplasias Cutáneas/etiologíaRESUMEN
Primary human keratinocytes (PHKs) are known to express the EP3 subtype of prostaglandin E2 receptor. To better understand the role of EP3 receptors in regulating epidermal function, we characterized their expression, localization, and signaling effects in human skin. Three different splice variants of the EP3 receptor (EP3A1, EP3C, and EP3D) were found to be expressed. Immunohistochemical analysis of human skin demonstrated that EP3 receptors were most prominently expressed in the basal and lower spinous layers of the epidermis. The EP3 receptor agonist sulprostone was then used to examine EP3 receptor-dependent keratinocyte signaling pathways and functional effects. We observed that sulprostone inhibits keratinocyte growth at doses between 0.02 and 2 nM and induces sn-1,2-diacylglycerol (DAG) and ceramide production. Concurrent expression of the cell-cycle inhibitory protein p21WAF1 also occurred. These data suggest that EP3 receptors produce epidermal growth inhibition through the action of DAG and ceramide second messengers.
Asunto(s)
Ceramidas/metabolismo , Diglicéridos/metabolismo , Queratinocitos/citología , Queratinocitos/metabolismo , Receptores de Prostaglandina E/fisiología , Western Blotting , Proliferación Celular , Células Cultivadas , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/metabolismo , ADN Recombinante , Epidermis/metabolismo , Humanos , Inmunohistoquímica , Receptores de Prostaglandina E/genética , Subtipo EP3 de Receptores de Prostaglandina E , Distribución TisularRESUMEN
Inhibition or deletion of cyclooxygenase (COX)-2 has been demonstrated to protect against squamous cell cancer in many studies. Although much effort has focused on COX-2 inhibition, recent work indicates that COX-1 deletion may be nearly as protective. In this study, we used SKH-1 hairless mice in which COX-1 was selectively deleted to examine the role of COX-1 in photocarcinogenesis. After UV exposure, 40-60% less prostaglandin E2 was detected in COX-1-/- animals compared with wild-type (WT) controls. A 4-fold induction of keratinocyte apoptosis was observed in knockouts relative to WT animals, as documented by terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling and caspase-3 staining. Proliferation was not significantly different in COX-1+/+, COX-1+/-, and COX-1-/- animals. When susceptibility to UV-induced tumor formation was studied, tumor number, average tumor size, and time of tumor onset in COX-1-/- animals were identical to WT controls. Thus, enhanced apoptosis did not alter UV-induced skin carcinogenesis, suggesting other effects are key to nonsteroidal anti-inflammatory drug chemoprevention. These results contrast sharply with data obtained using the classic 7,12-dimethylbenz(a)anthracene/12-O-tetradecanoylphorbol-13-acetate cancer model in which a prominent protective effect of COX-1-/- is present. The lack of protection observed here confirms cancer mechanisms are distinct in UV- and tumor promotor-induced cancer models and indicates that chemoprevention strategies must specifically address cancer causes to be effective.